<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Info | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-20T20:25:00+08:00</updated>
  <subtitle>传递医药信息，分享资源数据！充电5分钟，吹牛2小时！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>Alnylam公司第3款RNAi疗法获批！治疗1型原发性高草酸尿症</title>
    <updated>2020-11-20T17:57:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/UA_-rxBloYgI6IC8VqO4JA</id>
    <link href="https://mp.weixin.qq.com/s/UA_-rxBloYgI6IC8VqO4JA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>德琪医药正式在港交所上市</title>
    <updated>2020-11-20T17:57:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/IZrT68Ji7nFI1r2QFzAJ0A</id>
    <link href="https://mp.weixin.qq.com/s/IZrT68Ji7nFI1r2QFzAJ0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>荣昌生物c-Met靶点ADC新药RC108获批临床</title>
    <updated>2020-11-20T17:57:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/Op6M92QrnP9VDerBef5LJw</id>
    <link href="https://mp.weixin.qq.com/s/Op6M92QrnP9VDerBef5LJw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>江苏发布集采实施方案，医保定点零售药店参加采购联盟</title>
    <updated>2020-11-20T17:57:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/2TD0SWXKKQTv_Bk14Xl9Ew</id>
    <link href="https://mp.weixin.qq.com/s/2TD0SWXKKQTv_Bk14Xl9Ew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>先声药业「依达拉奉注射液」首家通过一致性评价</title>
    <updated>2020-11-19T18:38:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/sx3fj1qSBCWS-nsGVL91uA</id>
    <link href="https://mp.weixin.qq.com/s/sx3fj1qSBCWS-nsGVL91uA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>宜昌人福「盐酸安非他酮缓释片」首家通过一致性评价</title>
    <updated>2020-11-19T18:38:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/J2EieEf1whqAMc1yvqeCOQ</id>
    <link href="https://mp.weixin.qq.com/s/J2EieEf1whqAMc1yvqeCOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>扬子江「注射用头孢西丁钠」首家通过一致性评价</title>
    <updated>2020-11-19T18:38:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/RcdHJpIRR4a7l37ZoSdWLA</id>
    <link href="https://mp.weixin.qq.com/s/RcdHJpIRR4a7l37ZoSdWLA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默沙东first in class巨细胞病毒感染新药「来特莫韦」在中国申报上市</title>
    <updated>2020-11-18T18:50:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/FR3D4tyM83BugMHr8GwfBw</id>
    <link href="https://mp.weixin.qq.com/s/FR3D4tyM83BugMHr8GwfBw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>陈之键创立的这家公司完成2亿美元融资，药明康德为第一大股东</title>
    <updated>2020-11-18T18:50:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/XM2GSER1IHl-dN3PxUNvwg</id>
    <link href="https://mp.weixin.qq.com/s/XM2GSER1IHl-dN3PxUNvwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>齐鲁制药「盐酸美金刚口溶膜」申报上市</title>
    <updated>2020-11-18T18:50:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/d9nUPtDqJR7tK5eBMTdHig</id>
    <link href="https://mp.weixin.qq.com/s/d9nUPtDqJR7tK5eBMTdHig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一省提前开放第三批国采（含全国落地进展汇总）</title>
    <updated>2020-11-18T18:50:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/i5EGUE0RtPYQPv2nVrszcw</id>
    <link href="https://mp.weixin.qq.com/s/i5EGUE0RtPYQPv2nVrszcw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康哲药业「徳度司他片」申报临床</title>
    <updated>2020-11-18T18:50:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/hSNYMvA2rCKhz6UcBG2h8w</id>
    <link href="https://mp.weixin.qq.com/s/hSNYMvA2rCKhz6UcBG2h8w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>先声药业 CDK4/6抑制剂Trilaciclib提交临床申请</title>
    <updated>2020-11-18T18:50:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/ZUQPYmsyno3KC3RWWdbPTw</id>
    <link href="https://mp.weixin.qq.com/s/ZUQPYmsyno3KC3RWWdbPTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>补体C3抑制剂上市申请获FDA优先审评！挑战40亿美元重磅药物依库珠单抗</title>
    <updated>2020-11-17T17:52:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/-CMKelfzaL6z0ncufnknUQ</id>
    <link href="https://mp.weixin.qq.com/s/-CMKelfzaL6z0ncufnknUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>南京圣和1类新药「和乐布韦」申报上市</title>
    <updated>2020-11-17T17:52:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/a4CyRFLnvwsR3ajnj_LhrA</id>
    <link href="https://mp.weixin.qq.com/s/a4CyRFLnvwsR3ajnj_LhrA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州预计2021H1完成科创板IPO</title>
    <updated>2020-11-16T18:08:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/5vl5PcahBkwawuVCEMHPIQ</id>
    <link href="https://mp.weixin.qq.com/s/5vl5PcahBkwawuVCEMHPIQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药明生物“1拆3”，市值超过药明康德</title>
    <updated>2020-11-16T18:08:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/NIwudPMOzvIsBvCi98IftQ</id>
    <link href="https://mp.weixin.qq.com/s/NIwudPMOzvIsBvCi98IftQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>万春「普那布林」国际多中心III期临床试验获得阳性结果</title>
    <updated>2020-11-16T18:08:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/TaCocRM9siP8bEAyb2_iEg</id>
    <link href="https://mp.weixin.qq.com/s/TaCocRM9siP8bEAyb2_iEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>索马鲁肽联合cilofexo/firsocostat治疗NASH II期研究获积极结果</title>
    <updated>2020-11-16T18:08:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/Fg9rPTST-VnKj3N6L1-iLQ</id>
    <link href="https://mp.weixin.qq.com/s/Fg9rPTST-VnKj3N6L1-iLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州引进的HER2双抗获批临床</title>
    <updated>2020-11-16T18:08:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/RVbmKQGKkdyPRGkA0iocpg</id>
    <link href="https://mp.weixin.qq.com/s/RVbmKQGKkdyPRGkA0iocpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>